These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 30097452)
1. Interleukin 12 and interleukin 23 play key pathogenic roles in inflammatory and proliferative pathways in giant cell arteritis. Conway R; O'Neill L; McCarthy GM; Murphy CC; Fabre A; Kennedy S; Veale DJ; Wade SM; Fearon U; Molloy ES Ann Rheum Dis; 2018 Dec; 77(12):1815-1824. PubMed ID: 30097452 [TBL] [Abstract][Full Text] [Related]
2. Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways. Espígol-Frigolé G; Planas-Rigol E; Lozano E; Corbera-Bellalta M; Terrades-García N; Prieto-González S; García-Martínez A; Hernández-Rodríguez J; Grau JM; Cid MC Front Immunol; 2018; 9():809. PubMed ID: 29731755 [TBL] [Abstract][Full Text] [Related]
3. Regulation of Inflammation and Angiogenesis in Giant Cell Arteritis by Acute-Phase Serum Amyloid A. O'Neill L; Rooney P; Molloy D; Connolly M; McCormick J; McCarthy G; Veale DJ; Murphy CC; Fearon U; Molloy E Arthritis Rheumatol; 2015 Sep; 67(9):2447-56. PubMed ID: 26016600 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis. Terrier B; Geri G; Chaara W; Allenbach Y; Rosenzwajg M; Costedoat-Chalumeau N; Fouret P; Musset L; Benveniste O; Six A; Klatzmann D; Saadoun D; Cacoub P Arthritis Rheum; 2012 Jun; 64(6):2001-11. PubMed ID: 22147555 [TBL] [Abstract][Full Text] [Related]
5. Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis. Espígol-Frigolé G; Corbera-Bellalta M; Planas-Rigol E; Lozano E; Segarra M; García-Martínez A; Prieto-González S; Hernández-Rodríguez J; Grau JM; Rahman MU; Cid MC Ann Rheum Dis; 2013 Sep; 72(9):1481-7. PubMed ID: 22993227 [TBL] [Abstract][Full Text] [Related]
6. Mucosal-associated invariant T cells in Giant Cell Arteritis. Ghesquière T; Ciudad M; Ramon A; Greigert H; Gerard C; Cladière C; Thébault M; Genet C; Devilliers H; Maurier F; Ornetti P; Quipourt V; Gabrielle PH; Creuzot-Garcher C; Tarris G; Martin L; Soudry-Faure A; Saas P; Audia S; Bonnotte B; Samson M J Autoimmun; 2021 Jul; 121():102652. PubMed ID: 34000675 [TBL] [Abstract][Full Text] [Related]
7. DNA methylation analysis of the temporal artery microenvironment in giant cell arteritis. Coit P; De Lott LB; Nan B; Elner VM; Sawalha AH Ann Rheum Dis; 2016 Jun; 75(6):1196-202. PubMed ID: 26038090 [TBL] [Abstract][Full Text] [Related]
8. Arterial wall production of cytokines in giant cell arteritis: results of a pilot study using human temporal artery cultures. Blain H; Abdelmouttaleb I; Belmin J; Blain A; Floquet J; Guéant JL; Jeandel C J Gerontol A Biol Sci Med Sci; 2002 Apr; 57(4):M241-5. PubMed ID: 11909890 [TBL] [Abstract][Full Text] [Related]
9. Th1 and Th17 cytokines drive inflammation in Takayasu arteritis. Saadoun D; Garrido M; Comarmond C; Desbois AC; Domont F; Savey L; Terrier B; Geri G; Rosenzwajg M; Klatzmann D; Fourret P; Cluzel P; Chiche L; Gaudric J; Koskas F; Cacoub P Arthritis Rheumatol; 2015 May; 67(5):1353-60. PubMed ID: 25604824 [TBL] [Abstract][Full Text] [Related]
10. Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis. Corbera-Bellalta M; Planas-Rigol E; Lozano E; Terrades-García N; Alba MA; Prieto-González S; García-Martínez A; Albero R; Enjuanes A; Espígol-Frigolé G; Hernández-Rodríguez J; Roux-Lombard P; Ferlin WG; Dayer JM; Kosco-Vilbois MH; Cid MC Ann Rheum Dis; 2016 Jun; 75(6):1177-86. PubMed ID: 26698852 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of interleukin-22 in patients with giant cell arteritis. Zerbini A; Muratore F; Boiardi L; Ciccia F; Bonacini M; Belloni L; Cavazza A; Cimino L; Moramarco A; Alessandro R; Rizzo A; Parmeggiani M; Salvarani C; Croci S Rheumatology (Oxford); 2018 Jan; 57(1):64-72. PubMed ID: 28968695 [TBL] [Abstract][Full Text] [Related]
12. Th17 and Th1 T-cell responses in giant cell arteritis. Deng J; Younge BR; Olshen RA; Goronzy JJ; Weyand CM Circulation; 2010 Feb; 121(7):906-15. PubMed ID: 20142449 [TBL] [Abstract][Full Text] [Related]
13. IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis. Ciccia F; Alessandro R; Rizzo A; Raimondo S; Giardina A; Raiata F; Boiardi L; Cavazza A; Guggino G; De Leo G; Salvarani C; Triolo G Ann Rheum Dis; 2013 Feb; 72(2):258-64. PubMed ID: 22872024 [TBL] [Abstract][Full Text] [Related]
14. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Hernández-Rodríguez J; Segarra M; Vilardell C; Sánchez M; García-Martínez A; Esteban MJ; Grau JM; Urbano-Márquez A; Colomer D; Kleinman HK; Cid MC Circulation; 2003 May; 107(19):2428-34. PubMed ID: 12742994 [TBL] [Abstract][Full Text] [Related]
15. Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis. Nagel MA; White T; Khmeleva N; Rempel A; Boyer PJ; Bennett JL; Haller A; Lear-Kaul K; Kandasmy B; Amato M; Wood E; Durairaj V; Fogt F; Tamhankar MA; Grossniklaus HE; Poppiti RJ; Bockelman B; Keyvani K; Pollak L; Mendlovic S; Fowkes M; Eberhart CG; Buttmann M; Toyka KV; Meyer-ter-Vehn T; Petursdottir V; Gilden D JAMA Neurol; 2015 Nov; 72(11):1281-7. PubMed ID: 26349037 [TBL] [Abstract][Full Text] [Related]
16. Cytokine expression in temporal arteries: comparative analysis between patients with biopsy-positive giant cell arteritis, biopsy-negative giant cell arteritis and biopsy-negative without arteritis. Grossman C; Yassin N; Avivi C; Bornstein G; Ben-Zvi I; Barshack I Clin Exp Rheumatol; 2019; 37 Suppl 117(2):122-129. PubMed ID: 31162032 [TBL] [Abstract][Full Text] [Related]
17. Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis. Corbera-Bellalta M; Alba-Rovira R; Muralidharan S; Espígol-Frigolé G; Ríos-Garcés R; Marco-Hernández J; Denuc A; Kamberovic F; Pérez-Galán P; Joseph A; D'Andrea A; Bondensgaard K; Cid MC; Paolini JF Ann Rheum Dis; 2022 Apr; 81(4):524-536. PubMed ID: 35045965 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 does not upregulate pro-inflammatory cytokine expression in an O'Neill L; McCormick J; Gao W; Veale DJ; McCarthy GM; Murphy CC; Fearon U; Molloy ES Rheumatol Adv Pract; 2019; 3(1):rkz011. PubMed ID: 31431999 [TBL] [Abstract][Full Text] [Related]